3.70
price down icon14.35%   -0.62
after-market After Hours: 3.65 -0.05 -1.35%
loading
Solid Biosciences Inc stock is traded at $3.70, with a volume of 2.11M. It is down -14.35% in the last 24 hours and down -33.81% over the past month.
See More
Previous Close:
$4.32
Open:
$3.91
24h Volume:
2.11M
Relative Volume:
0.94
Market Cap:
$370.42M
Revenue:
$14.79M
Net Income/Loss:
$-102.44M
P/E Ratio:
-1.2171
EPS:
-3.04
Net Cash Flow:
$-91.73M
1W Performance:
-22.59%
1M Performance:
-33.81%
6M Performance:
-46.92%
1Y Performance:
-72.22%
1-Day Range:
Value
$3.5001
$4.05
1-Week Range:
Value
$3.5001
$4.86
52-Week Range:
Value
$2.88
$13.47

Solid Biosciences Inc Stock (SLDB) Company Profile

Name
Name
Solid Biosciences Inc
Name
Phone
617-337-4680
Name
Address
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Name
Employee
0
Name
Twitter
@SolidBioDMD
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
SLDB's Discussions on Twitter

Compare SLDB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SLDB
Solid Biosciences Inc
3.70 370.42M 14.79M -102.44M -91.73M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-08-25 Initiated Truist Buy
Dec-13-24 Initiated Wedbush Outperform
Dec-10-24 Initiated JMP Securities Mkt Outperform
Jul-15-24 Upgrade JP Morgan Neutral → Overweight
Jun-24-24 Upgrade Leerink Partners Market Perform → Outperform
May-31-24 Resumed Piper Sandler Overweight
Mar-28-24 Initiated William Blair Outperform
Mar-15-24 Initiated Citigroup Buy
Mar-14-24 Upgrade Piper Sandler Neutral → Overweight
Dec-08-23 Initiated H.C. Wainwright Buy
Jul-12-21 Initiated Piper Sandler Neutral
May-27-21 Initiated Jefferies Buy
Mar-16-21 Upgrade SVB Leerink Mkt Perform → Outperform
Mar-09-21 Initiated Barclays Overweight
Jan-08-21 Upgrade Credit Suisse Underperform → Neutral
Jul-28-20 Downgrade SVB Leerink Outperform → Mkt Perform
May-07-20 Downgrade Evercore ISI Outperform → In-line
Oct-11-19 Initiated Evercore ISI Outperform
Aug-29-19 Downgrade Citigroup Neutral → Sell
Aug-19-19 Upgrade SVB Leerink Mkt Perform → Outperform
Aug-16-19 Upgrade Chardan Capital Markets Neutral → Buy
May-14-19 Downgrade Credit Suisse Neutral → Underperform
May-14-19 Downgrade Goldman Neutral → Sell
Feb-08-19 Upgrade Citigroup Sell → Neutral
Feb-08-19 Downgrade SVB Leerink Outperform → Mkt Perform
Nov-06-18 Initiated Citigroup Sell
Sep-06-18 Initiated Credit Suisse Neutral
View All

Solid Biosciences Inc Stock (SLDB) Latest News

pulisher
Mar 20, 2025

Sarepta safety update on Elevidys boosts Regenxbio, hurts Solid Bio - MSN

Mar 20, 2025
pulisher
Mar 19, 2025

Solid Biosciences Inc.'s (NASDAQ:SLDB) market cap dropped US$53m last week; Private equity firms bore the brunt - simplywall.st

Mar 19, 2025
pulisher
Mar 18, 2025

Regenxbio stock up, Solid Bio down post Sarepta update (RGNX) - Seeking Alpha

Mar 18, 2025
pulisher
Mar 14, 2025

Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month - Insider Monkey

Mar 14, 2025
pulisher
Mar 13, 2025

Solid Biosciences director Kahn Clare buys $9,924 in stock - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences director Kahn Clare buys $9,924 in stock By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences’ SWOT analysis: gene therapy firm’s stock poised for growth - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences’ SWOT analysis: gene therapy firm’s stock poised for growth By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Solid Biosciences Inc. (NASDAQ:SLDB) Short Interest Update - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Q1 EPS Forecast for Solid Biosciences Boosted by Analyst - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Top 10 Insider Purchases Last Month - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Solid Biosciences Inc. to Present Phase 1/2 INSPIRE DUCHENNE Trial Data on SGT-003 Gene Therapy for Duchenne Muscular Dystrophy at 2025 MDA Conference - Nasdaq

Mar 12, 2025
pulisher
Mar 12, 2025

Breakthrough DMD Gene Therapy Results: Solid Bio Reveals INSPIRE Trial Data at Major Conference - StockTitan

Mar 12, 2025
pulisher
Mar 11, 2025

Solid Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Solid Biosciences Inc. (NASDAQ:SLDB) Shares Acquired by Rhumbline Advisers - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

HC Wainwright Issues Positive Forecast for Solid Biosciences (NASDAQ:SLDB) Stock Price - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Solid Biosciences shares leap on raised price target to $20 By Investing.com - Investing.com Canada

Mar 10, 2025
pulisher
Mar 10, 2025

Solid Biosciences price target raised to $20 from $16 at H.C. Wainwright - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

FY2026 Earnings Forecast for SLDB Issued By William Blair - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Chardan Capital Reaffirms “Buy” Rating for Solid Biosciences (NASDAQ:SLDB) - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

SLDB Stock Rallies 60% in a Month: Here's What You Should Know - MSN

Mar 07, 2025
pulisher
Mar 07, 2025

Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences Inc expected to post a loss of 60 cents a shareEarnings Preview - TradingView

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences stock target holds at $15 on therapy optimism - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences: Promising Gene Therapy Advancements and Strategic Pipeline Expansion Justify Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences: Positive DMD Program Developments and Strong Financial Position Justify Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire

Mar 07, 2025
pulisher
Mar 06, 2025

Solid Biosciences Inc. (SLDB) reports earnings - Quartz

Mar 06, 2025
pulisher
Mar 06, 2025

Solid Biosciences reports Q4 EPS ($1.00), consensus (78c) - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Solid Biosciences Reports Positive Data from Duchenne Gene Therapy Trial and Provides Business Update - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

Solid Biosciences Inc. SEC 10-K Report - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

SLDBSolid Bioscience Latest Stock News & Market Updates - Stock Titan

Mar 06, 2025
pulisher
Mar 05, 2025

Duchenne Patient Stories - Solid Biosciences

Mar 05, 2025
pulisher
Mar 05, 2025

Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewswire

Mar 05, 2025
pulisher
Mar 05, 2025

Genetic Medicine Developer Solid Biosciences Sets March Conference Schedule: What's Coming? - StockTitan

Mar 05, 2025
pulisher
Mar 05, 2025

Solid Biosciences (SLDB) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Is Solid Biosciences Inc. (SLDB) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

How Solid Biosciences Uses Equity Compensation to Attract New Talent - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

3 Reasons to Sell CSL and 1 Stock to Buy Instead - The Globe and Mail

Mar 03, 2025
pulisher
Mar 01, 2025

Solid Biosciences Inc. (SLDB) Latest Stock News & Headlines - Yahoo Canada Finance

Mar 01, 2025
pulisher
Feb 28, 2025

Leerink Partnrs Issues Optimistic Outlook for SLDB Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Solid Biosciences Inc.'s (NASDAQ:SLDB) stock price dropped 11% last week; individual investors would not be happy - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%. - The Globe and Mail

Feb 28, 2025
pulisher
Feb 28, 2025

What is Chardan Capital's Forecast for SLDB FY2025 Earnings? - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Solid Biosciences Inc [SLDB] stock for 4,030,000 USD was bought by Bain Capital Life Sciences Inv - Knox Daily

Feb 27, 2025

Solid Biosciences Inc Stock (SLDB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Cap:     |  Volume (24h):